Destroying the androgen receptor (AR)-potential strategy to treat advanced prostate cancer

Oncoscience. 2017 Dec 28;4(11-12):175-177. doi: 10.18632/oncoscience.389. eCollection 2017 Nov.
No abstract available

Keywords: androgen receptor; castration-resistant prostate cancer (CRPC); selective androgen receptor degraders (SARDs); ubiquitin proteasome pathway.

Publication types

  • Editorial